Cargando…

A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues

PURPOSE: Prostate-specific antigen (PSA)-based screening for prostate cancer (PC) has dramatically increased early diagnosis. Current imaging techniques are not optimal to stage early PC adequately. A promising alternative to PC imaging is peptide-based scintigraphy using radiolabelled bombesin (BN)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schroeder, Rogier P. J., Müller, Cristina, Reneman, Suzanne, Melis, Marleen L., Breeman, Wout A. P., de Blois, Erik, Bangma, Chris H., Krenning, Eric P., van Weerden, Wytske M., de Jong, Marion
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886136/ https://www.ncbi.nlm.nih.gov/pubmed/20182713 http://dx.doi.org/10.1007/s00259-010-1388-2

Ejemplares similares

Gastrin-releasing peptide receptor-based targeting using bombesin analogues is superior to metabolism-based targeting using choline for in vivo imaging of human prostate cancer xenografts
por: Schroeder, Rogier P. J., et al.
Publicado: (2011)

Radiolabeled Bombesin Analogs
por: Mansi, Rosalba, et al.
Publicado: (2021)

Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma
por: Fröberg, Alida C., et al.
Publicado: (2009)

Targeting prostate cancer with radiolabelled bombesins
por: Maina, Theodosia, et al.
Publicado: (2006)

Dose-response effect of Gelofusine on renal uptake and retention of radiolabelled octreotate in rats with CA20948 tumours
por: Melis, Marleen, et al.
Publicado: (2009)

HYNIC and DOMA conjugated radiolabeled bombesin analogs as receptor-targeted probes for scintigraphic detection of breast tumor
por: De, Kakali, et al.
Publicado: (2019)

Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amount
por: Konijnenberg, Mark W, et al.
Publicado: (2014)

Reduction of (68)Ge activity containing liquid waste from (68)Ga PET chemistry in nuclear medicine and radiopharmacy by solidification
por: de Blois, Erik, et al.
Publicado: (2010)

Evaluation of a new radiolabeled bombesin derivative with (99m)Tc as potential targeted tumor imaging agent
por: Sadeghzadeh, N., et al.
Publicado: (2013)

Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: de Keizer, Bart, et al.
Publicado: (2008)

Bombesin and bombesin antagonists: studies in Swiss 3T3 cells and human small cell lung cancer.
por: Woll, P. J., et al.
Publicado: (1988)

(68)Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation
por: Hajiramezanali, Maliheh, et al.
Publicado: (2019)

Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers
por: Murce, Erika, et al.
Publicado: (2023)

Positron Emission Tomography Imaging of the Gastrin-Releasing Peptide Receptor with a Novel Bombesin Analogue
por: Lau, Joseph, et al.
Publicado: (2019)

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [(177)Lu-DOTA(0),Tyr(3)]octreotate
por: Kwekkeboom, D. J., et al.
Publicado: (2003)

New Radiolabeled Exendin Analogues Show Reduced Renal Retention
por: Joosten, Lieke, et al.
Publicado: (2023)

Bombesin Analogue-Mediated Delivery Preferentially Enhances the Cytotoxicity of a Mitochondria-Disrupting Peptide in Tumor Cells
por: Yang, Hao, et al.
Publicado: (2013)

Radiolabeled Somatostatin Analogues for Diagnosis and Treatment of Neuroendocrine Tumors
por: Ambrosini, Valentina, et al.
Publicado: (2022)

SPECT/CT with radiolabeled somatostatin analogues in the evaluation of systemic granulomatous infections
por: Monteiro, Paulo Henrique Silva, et al.
Publicado: (2017)

Peptide receptor radionuclide therapy using radiolabeled somatostatin analogs: focus on future developments
por: Bison, Sander M., et al.
Publicado: (2014)

Renal uptake of different radiolabelled peptides is mediated by megalin: SPECT and biodistribution studies in megalin-deficient mice
por: Vegt, Erik, et al.
Publicado: (2010)

Role of the neuropeptide, bombesin, in bile secretion.
por: Cho, W. K.
Publicado: (1997)

Targeted cytotoxic analogue of bombesin/ gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice
por: Kiaris, H, et al.
Publicado: (1999)

Stress and eating: a dual role for bombesin-like peptides
por: Merali, Z., et al.
Publicado: (2013)

Radiolabeled Somatostatin Analogues Therapy in Advanced Neuroendocrine Tumors: A Single Centre Experience
por: Filice, A., et al.
Publicado: (2012)

Effective treatment of experimental U-87MG human glioblastoma in nude mice with a targeted cytotoxic bombesin analogue, AN-215
por: Szereday, Z, et al.
Publicado: (2002)

Scintigraphic imaging of small-cell lung cancer with [111In]pentetreotide, a radiolabelled somatostatin analogue.
por: O'Byrne, K. J., et al.
Publicado: (1994)

Bombesine in critically ill patients receiving enteral and total parenteral nutrition
por: Moukas, M, et al.
Publicado: (2002)

Is there a clinical usefulness for radiolabeled somatostatin analogues beyond the consolidated role in NETs?
por: Cuccurullo, Vincenzo, et al.
Publicado: (2017)

Evolution of Bombesin Conjugates for Targeted PET Imaging of Tumors
por: Zhang, Hanwen, et al.
Publicado: (2012)

Molecular recognition of itch-associated neuropeptides by bombesin receptors
por: Li, Changyao, et al.
Publicado: (2022)

Bombesins: A New Frontier in Hybrid Compound Development
por: Serafin, Pawel, et al.
Publicado: (2023)

Patient-Derived Xenograft Models in Cancer Research
por: van Weerden, Wytske M.
Publicado: (2021)

Human xenograft models as useful tools to assess the potential of novel therapeutics in prostate cancer
por: van Weerden, W M, et al.
Publicado: (2009)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
por: Ruigrok, Eline A.M., et al.
Publicado: (2019)

Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method
por: Mueller, Dirk, et al.
Publicado: (2016)

Correction to: In vitro dose effect relationships of actinium‑225‑ and lutetium‑177‑labeled PSMA‑I&T
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

In vitro dose effect relationships of actinium-225- and lutetium-177-labeled PSMA-I&T
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Preclinical Assessment of the Combination of PSMA-Targeting Radionuclide Therapy with PARP Inhibitors for Prostate Cancer Treatment
por: Ruigrok, Eline A. M., et al.
Publicado: (2022)

Bombesin stimulates proliferation of human breast cancer cells in culture.
por: Nelson, J., et al.
Publicado: (1991)

Cannot write session to /tmp/vufind_sessions/sess_7fjiji8t402lom7bsq76pki474